Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Klaus F. Rabe

Arzt

Name

Klaus F. Rabe

Place

Kiel (Wirkungsort)
Deutschland

Gender

männlich

Academic degree

Prof. Dr. med.

Profession

Arzt (characteristic profession)

Variant

Klaus Rabe
K. F. Rabe
Klaus Friedrich Rabe

Further information

Translational Lung Research Center Heidelberg; 2017- Präsident der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP)

Record type

Person

GND-Identifier

142581453

Record ID

142581453

Involved in

show all

Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

S2k-Leitlinie zur fachärztlichen Diagnostik und Therapie von Asthma 2023 : herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.

Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians

Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians

Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Risikoabschätzung bei Patienten mit chronischen Atemwegs- und Lungenerkrankungen im Rahmen der SARS-CoV-2-Pandemie : Stellungnahme der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) mit Unterstützung des Bundesverbands der Pneumologen, Schlaf- und Beatmungsmediziner e. V. (BdP)

Correction to: Key summary of German national treatment guidance for hospitalized COVID‑19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021)

Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis

Der Phosphodiesterase-4-Hemmer-Roflumilast : Fortschritt bei der Therapie der COPD

Inhalative Glukokortikoide zur Therapie obstruktiver Ventilationsstörungen
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal